Preclinical studies suggest GLP-1 agonists may reduce certain inflammatory markers, but these findings have not been validated in rheumatoid arthritis clinical trials
Will substances be mixed, and what compatibility data support that mixture
(And the side effects arent minor nausea, vomiting, dehydration, constipation, and more serious risks like pancreatitis or kidney issues can all occur.) And because they don't closely monitor progress, they also don't initiate a change of plan or medication as the patient changes
We fear that children and adolescents participating in weight-sensitive activities such as wrestling, bodybuilding, cheerleading, gymnastics, or dance might be particularly vulnerable to unsupervised acquisition and use of these medications
MalhotraAGrunsteinRRFietzeIWeaverTERedlineSAzarbarzinAet alTirzepatide for the treatment of obstructive sleep apnea and obesity